Use of F18-FDG PET for evaluation of primary pulmonary melanoma
Siroos Mirzaei, Wilhelminenspital
5 January 2004
In their very interesting publication Dountsis et al. describe the case of a patient with primary malignant melanoma of the lung. However, we miss in their clinical procedure of exclusion of other malignant primary sites the use of F18-FDG positron emission tomography (PET) which should be the primary cost-effective modality for further evaluation of the patient.
Competing interests
none
Dad
Glenn Yokel, N/A
25 April 2007
Regarding, "Primary Malignant Melanoma of the Lung: A Case Report".
After reading this case report about the 41 year old female with primary malignant melanoma of the lung, I submit this comment hoping it reaches someone with insight on the subject.
About a year ago, my Dad presented with MM in his lymph nodes. While a surgical procedure was performed, the MM spread to his lungs.
He then participated in a clinical trial that used a new monoclonal antibody to target the MM. It was unfortunately ineffective. Any vaccines, clinical trials or non invasive procedures - other than chemotherapy - currently available to treat MM in the lungs?
Use of F18-FDG PET for evaluation of primary pulmonary melanoma
5 January 2004
In their very interesting publication Dountsis et al. describe the case of a patient with primary malignant melanoma of the lung. However, we miss in their clinical procedure of exclusion of other malignant primary sites the use of F18-FDG positron emission tomography (PET) which should be the primary cost-effective modality for further evaluation of the patient.
Competing interests
none
Dad
25 April 2007
Regarding, "Primary Malignant Melanoma of the Lung: A Case Report".
After reading this case report about the 41 year old female with primary malignant melanoma of the lung, I submit this comment hoping it reaches someone with insight on the subject.
About a year ago, my Dad presented with MM in his lymph nodes. While a surgical procedure was performed, the MM spread to his lungs.
He then participated in a clinical trial that used a new monoclonal antibody to target the MM. It was unfortunately ineffective. Any vaccines, clinical trials or non invasive procedures - other than chemotherapy - currently available to treat MM in the lungs?
Sincerely,
Glenn Yokel
732-901-6890
glennyokel@aol.com
Competing interests
None declared